BEVACIZUMAB AND FOTEMUSTINE AS SALVAGE THERAPY IN RECURRENT GLIOBLASTOMA: A PHASE II MULTICENTER ITALIAN STUDY

被引：0
|
作者：
Trevisan, E. [1 ]
Ruda, R. [1 ]
Picco, E. [1 ]
Crasto, S. Greco [2 ]
Caroli, M. [3 ]
Fabrini, A. [4 ]
Scotti, V. [4 ]
Lolli, I.
Guarneri, D. [1 ]
Soffietti, R. [1 ]
机构：
[1] Neurooncol Dept, Turin, Italy
[2] Dept Radiol, Turin, Italy
[3] Dept Neurosurg, Turin, Italy
[4] Dept Radiotherapy, Pisa, Italy
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [1] Bevacizumab and Fotemustine for Recurrent Glioblastoma - Final Results of a Multicenter Phase II Study of AINO (Italian Association of Neuro-Oncology)
    Trevisan, E.
    Ruda, R.
    Bertero, L.
    Bosa, C.
    Ciccone, G.
    Morra, I.
    Fabrini, M. G.
    Lolli, I.
    Soffietti, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S576 - S576
  • [2] Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
    Riccardo Soffietti
    Elisa Trevisan
    Luca Bertero
    Paola Cassoni
    Isabella Morra
    Maria Grazia Fabrini
    Francesco Pasqualetti
    Ivan Lolli
    Anna Castiglione
    Giovannino Ciccone
    Roberta Rudà
    Journal of Neuro-Oncology, 2014, 116 : 533 - 541
  • [3] Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
    Soffietti, Riccardo
    Trevisan, Elisa
    Bertero, Luca
    Cassoni, Paola
    Morra, Isabella
    Fabrini, Maria Grazia
    Pasqualetti, Francesco
    Lolli, Ivan
    Castiglione, Anna
    Ciccone, Giovannino
    Ruda, Roberta
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (03) : 533 - 541
  • [4] Phase II trial of bevacizumab with fotemustine in recurrent glioblastoma: Final results of a multicenter study of AINO (Italian Association of Neuro-oncology).
    Soffietti, R.
    Trevisan, E.
    Ruda, R.
    Bertero, L.
    Bosa, C.
    Fabrini, M. G.
    Lolli, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] PHASE II TRIAL OF BEVACIZUMAB WITH FOTEMUSTINE IN RECURRENT GLIOBLASTOMA: FINAL RESULTS OF A MULTICENTER STUDY OF AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY)
    Soffietti, Riccardo
    Trevisan, Elisa
    Ruda, Roberta
    Bertero, Luca
    Bosa, Chiara
    Fabrini, Maria Grazia
    Lolli, Ivan
    NEURO-ONCOLOGY, 2011, 13 : 56 - 57
  • [6] Salvage therapy with bevacizumab and fotemustine in recurrent high grade gliomas: an Italian multicentre study
    Trevisan, E.
    Ruda, R.
    Picco, E.
    Crasto, S. Greco
    Gaidolfi, E.
    Fabrini, M. G.
    Scotti, V.
    Lolli, I.
    Caroli, M.
    Guarneri, D.
    Soffietti, R.
    JOURNAL OF NEUROLOGY, 2010, 257 : S48 - S48
  • [7] BEVACIZUMAB IN COMBINATION WITH FOTEMUSTINE AS SALVAGE THERAPY IN RECURRENT ANAPLASTIC GLIOMAS: A PHASE II TRIAL
    Trevisan, E.
    Magistrello, M.
    Bertero, L.
    Bosa, C.
    Crasto, S. Greco
    Garbossa, D.
    Lolli, I.
    Ruda, R.
    Soffietti, R.
    NEURO-ONCOLOGY, 2012, 14 : 50 - 50
  • [8] A PHASE II STUDY OF AINO (ITALIAN ASSOCIATIONOF NEURO-ONCOLOGY) ON BEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT GLIOBLASTOMA: OUTCOME, PATTERNS OF RELAPSE AND SALVAGE TREATMENTS
    Trevisan, E.
    Bertero, L.
    Cassoni, P.
    Morra, I.
    Pasqualetti, F.
    Lolli, I.
    Castiglione, A.
    Ciccone, G.
    Ruda, R.
    Soffietti, R.
    NEURO-ONCOLOGY, 2014, 16
  • [9] Salvage therapy with bevacizumab and fotemustine in recurrent high grade gliomas
    Trevisan, E.
    Picco, E.
    Ruda, R.
    Crasto, S. Greco
    Fabrini, M. G.
    Scotti, V.
    Caroli, M.
    Lolli, I.
    Guarneri, D.
    Soffietti, R.
    EJC SUPPLEMENTS, 2009, 7 (02): : 499 - 499
  • [10] SALVAGE THERAPY WITH BEVACIZUMAB AND FOTEMUSTINE IN RECURRENT HIGH GRADE GLIOMAS
    Ruda, Roberta
    Trevisan, Elisa
    Picco, Elisabetta
    Crasto, Stefania Greco
    Fabrini, Maria Grazia
    Scotti, Valerio
    Caroli, Manuela
    Lolli, Ivan
    Guarneri, Daniele
    Soffietti, Riccardo
    ANNALS OF ONCOLOGY, 2009, 20
12345